Sponsored Links
| Everist Genomics Announces New Data On OncoDefender™- CRC Test For Predicting Recurrence Risk For Stage I And II Colorectal Cancer Patients |
 |
 |
 |
| Medical News - Colorectal Cancer | |||
|
Everist Genomics announced updated results from a study of its OncoDefender-CRC assay, a molecular prognostic test for early-stage colorectal cancer patients, will be presented at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting, which will be held June 3-7, 2011, in Chicago... Read more: Colorectal Cancer News From Medical News Today
|